These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

783 related items for PubMed ID: 15994438

  • 1. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
    Ohtsu H, Mifune M, Frank GD, Saito S, Inagami T, Kim-Mitsuyama S, Takuwa Y, Sasaki T, Rothstein JD, Suzuki H, Nakashima H, Woolfolk EA, Motley ED, Eguchi S.
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
    [Abstract] [Full Text] [Related]

  • 2. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
    Kyaw M, Yoshizumi M, Tsuchiya K, Kagami S, Izawa Y, Fujita Y, Ali N, Kanematsu Y, Toida K, Ishimura K, Tamaki T.
    Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
    Ying Z, Jin L, Palmer T, Webb RC.
    Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
    Lemarié CA, Simeone SM, Nikonova A, Ebrahimian T, Deschênes ME, Coffman TM, Paradis P, Schiffrin EL.
    Circ Res; 2009 Oct 23; 105(9):852-9. PubMed ID: 19762686
    [Abstract] [Full Text] [Related]

  • 7. [Role of Rho-Rock pathways induced by angiotensin II in hepatic stellate cell contraction].
    Zhang XL, Xiao B, Li X, Huang ML, Meng Y, Li YF, Wang YY, Song WB.
    Zhonghua Yi Xue Za Zhi; 2008 Sep 09; 88(34):2422-6. PubMed ID: 19087721
    [Abstract] [Full Text] [Related]

  • 8. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
    Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y.
    Circulation; 2004 Jul 27; 110(4):444-51. PubMed ID: 15262850
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells.
    Touyz RM, Yao G, Schiffrin EL.
    Can J Physiol Pharmacol; 2005 Jan 27; 83(1):91-7. PubMed ID: 15759055
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
    Sahar S, Dwarakanath RS, Reddy MA, Lanting L, Todorov I, Natarajan R.
    Circ Res; 2005 May 27; 96(10):1064-71. PubMed ID: 15860756
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells.
    Mazak I, Fiebeler A, Muller DN, Park JK, Shagdarsuren E, Lindschau C, Dechend R, Viedt C, Pilz B, Haller H, Luft FC.
    Circulation; 2004 Jun 08; 109(22):2792-800. PubMed ID: 15159288
    [Abstract] [Full Text] [Related]

  • 15. Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathway.
    Weiss S, Frischknecht K, Greutert H, Payeli S, Steffel J, Lüscher TF, Carrel TP, Tanner FC.
    J Vasc Res; 2007 Jun 08; 44(2):149-56. PubMed ID: 17264516
    [Abstract] [Full Text] [Related]

  • 16. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
    Guilluy C, Rolli-Derkinderen M, Loufrani L, Bourgé A, Henrion D, Sabourin L, Loirand G, Pacaud P.
    Circ Res; 2008 May 23; 102(10):1265-74. PubMed ID: 18420945
    [Abstract] [Full Text] [Related]

  • 17. Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-beta in angiotensin II-stimulated vascular smooth muscle cells.
    Frank GD, Eguchi S, Motley ED, Sasaki T, Inagami T.
    Biochem Biophys Res Commun; 2001 Aug 31; 286(4):692-6. PubMed ID: 11520052
    [Abstract] [Full Text] [Related]

  • 18. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
    Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, Terao J, Tamaki T.
    Biochem Biophys Res Commun; 2002 May 24; 293(5):1458-65. PubMed ID: 12054679
    [Abstract] [Full Text] [Related]

  • 19. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
    Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M.
    Circ Res; 2005 Sep 02; 97(5):434-42. PubMed ID: 16081869
    [Abstract] [Full Text] [Related]

  • 20. Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.
    Zhou CH, Wu XH, Wu YQ.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):55-60. PubMed ID: 19486902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.